Literature DB >> 24139457

The effect of preoperative β-blocker use and race on long-term survival after coronary artery bypass grafting.

Wesley T O'Neal1, Jimmy T Efird2, Hope Landrine3, Curtis A Anderson4, Stephen W Davies5, Jason B O'Neal6, T Bruce Ferguson4, W Randolph Chitwood4, Alan P Kypson4.   

Abstract

OBJECTIVE: To date, racial differences in the long-term survival of coronary artery bypass grafting (CABG) patients who receive preoperative β-blockers have not been specifically examined. The purpose of this study was to examine the effect of preoperative β-blockers on long-term survival among black CABG patients and to compare the magnitude of this effect with white patients.
DESIGN: A retrospective cohort study.
SETTING: A tertiary referral heart hospital. PARTICIPANTS: 13,354 patients undergoing CABG between 1992 and 2011.
MEASUREMENTS AND MAIN RESULTS: Hazard ratios (HR) and 95% confidence intervals (CI) were computed using a Cox regression model. A total of 1,448 (62%) black and 6,094 (55%) white patients had a history of preoperative β-blocker use. Among black patients, those receiving β-blockers survived longer than those not receiving β-blockers (adjusted HR = 0.77, 95% CI = 0.67-0.88). The survival advantage was comparable to that observed among white patients (adjusted HR = 0.88, 95% CI = 0.82-0.93).
CONCLUSION: Black CABG patients benefited from preoperative β-blockers and the magnitude of the effect was comparable to that among white patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CABG; long-term; mortality; survival; β-blockers

Mesh:

Substances:

Year:  2013        PMID: 24139457     DOI: 10.1053/j.jvca.2013.06.009

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Differential Outcomes by Race and Ethnicity in Patients with Coronary Heart Disease: A Contemporary Review.

Authors:  Heidi Mochari-Greenberger; Lori Mosca
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-05

Review 2.  Population-level differences in revascularization treatment and outcomes among various United States subpopulations.

Authors:  Garth Graham; Yang-Yu Karen Xiao; Dan Rappoport; Saima Siddiqi
Journal:  World J Cardiol       Date:  2016-01-26

3.  Increased Long-Term Mortality among Black CABG Patients Receiving Preoperative Inotropic Agents.

Authors:  Jimmy T Efird; William F Griffin; Daniel F Sarpong; Stephen W Davies; Iulia Vann; Nathaniel T Koutlas; Ethan J Anderson; Patricia B Crane; Hope Landrine; Linda Kindell; Zahra J Iqbal; T Bruce Ferguson; W Randolph Chitwood; Alan P Kypson
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

4.  Increased coronary artery disease severity in black women undergoing coronary bypass surgery.

Authors:  Jimmy T Efird; Wesley T O'Neal; William F Griffin; Ethan J Anderson; Stephen W Davies; Hope Landrine; Jason B O'Neal; Kristin Y Shiue; Linda C Kindell; T Bruce Ferguson; W Randolph Chitwood; Alan P Kypson
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

5.  Risk-adjusted survival after coronary artery bypass grafting: implications for quality improvement.

Authors:  Jimmy T Efird; Wesley T O'Neal; Stephen W Davies; Jason B O'Neal; Linda C Kindell; Curtis A Anderson; W Randolph Chitwood; T Bruce Ferguson; Alan P Kypson
Journal:  Int J Environ Res Public Health       Date:  2014-07-21       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.